Immunosuppressive strategies in organ transplantation in the light of innate immunity.
Evidence has accumulated to support the notion that injury-induced activation of the donor's and the recipient's innate immune system largely determines the outcome of organ transplantation. Future potential therapeutic strategies to suppress events of both innate immune systems, as well as approaches to mitigate allograft injury, are discussed with regard to inhibiting both complement activation and dendritic cell maturation, and to blocking innate effector functions. Applications of pharmacological drug therapy as well as gene-specific manipulations are theoretical tools to reach these goals. A variety of encouraging experimental data in this research field are already available and promise further discoveries that ultimately will lead to the design of appropriate clinical trials.
Land
Walter Gottlieb
WG
Baskent University, Ankara, Turkey. walterland@aol.com
D000818:Animals; D003713:Dendritic Cells / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods*; D016377:Organ Transplantation; D014181:Transplantation Immunology / Q000276:immunology*